Cargando…
Co‐immunization with L‐Myc enhances CD8(+) or CD103(+) DCs mediated tumor‐specific multi‐functional CD8(+) T cell responses
Renal carcinoma shows a high risk of invasion and metastasis without effective treatment. Herein, we developed a chitosan (CS) nanoparticle‐mediated DNA vaccine containing an activated factor L‐Myc and a tumor‐specific antigen CAIX for renal carcinoma treatment. The subcutaneous tumor models were in...
Autores principales: | Chai, Dafei, Zhang, Zichun, Jiang, Nan, Ding, Jiage, Qiu, Dong, Shi, Shang Yuchen, Wang, Gang, Fang, Lin, Li, Huizhong, Tian, Hui, Yang, Jie, Zhang, Qing, Zheng, Junnian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409417/ https://www.ncbi.nlm.nih.gov/pubmed/34157192 http://dx.doi.org/10.1111/cas.15044 |
Ejemplares similares
-
Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity
por: Chai, Dafei, et al.
Publicado: (2021) -
The Closely Related CD103(+) Dendritic Cells (DCs) and Lymphoid-Resident CD8(+) DCs Differ in Their Inflammatory Functions
por: Jiao, Zhijun, et al.
Publicado: (2014) -
Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8(+) T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma
por: Zheng, Yanyan, et al.
Publicado: (2022) -
Mesenchymal stem cells alleviate rat diabetic nephropathy by suppressing CD103(+) DCs‐mediated CD8(+) T cell responses
por: Zhang, Fuping, et al.
Publicado: (2020) -
HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8(+)T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma
por: Shi, Xiaoqing, et al.
Publicado: (2023)